• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Copley Scientific banner
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Paul Young and Daniela Traini head up new Respiratory Technology Group

Paul M. Young and Daniela Traini have moved from the Pharmacy Faculty at the University of Sydney to the Woolcock Institute of Medical Research (WIMR) in order to establish a new Respiratory Technology team at the Institute.

According to Young and Traini, “The WIMR is a world leading respiratory and sleep research organization whose aim is to foster, develop and promote research into the areas of respiratory and sleep medicine. The Institute has over 200 academic researchers based at its purpose built facilities in Sydney and affiliated clinical centers and hospitals. The WIMR is cross-disciplinary and has groups in the areas of cell biology, epidemiology, lung imaging & physiology and clinical management. The Respiratory Technology team will be able to bridge fundamental biological sciences with the clinic and focus on the development and understanding of innovative inhalation medicines for the treatment of lung disease.”

The team’s new formulation, engineering, and characterization laboratory facilities will open officially in January 2013. Projects undertaken by the group include “aerosol particle generation, medical device design, development of new characterization tools, computational methodology and understanding the fate of particles after they deposit in the lung.”

Visit the Respiratory Technology Group website.

Share

published on December 20, 2012

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Proveris_180x150a
    © 2025 OINDPnews